Small Molecule Outsourcing STREAM

  1. Cambrex Scientist Spotlight: Daniel Kirschner 1/29/2025

    With a Ph.D. in bioanalytical chemistry from the University of Alaska Fairbanks, Kirschner brings nearly 15 years of experience in pharmaceutical development across biotech and CDMO sectors.

  2. The Fusion-Based, Solvent-Free Process Disrupting Spray Drying 3/19/2024

    Review a commercially-ready process capable of reproducing spray-dried dispersions with less manufacturing complexity and environmental impact, and out-designing and outperforming spray drying.

  3. Overcoming Challenges In Ophthalmic Formulations 8/27/2025

    Discover key strategies for overcoming formulation challenges in ophthalmic drug development and learn how selecting the right excipients supports quality, compliance, and safety.

  4. Understanding Nitrosamines: Key Regulations And Best Practices 10/2/2024

    Gain expert insights into nitrosamine regulations and discover practical strategies for ensuring compliance and safeguarding product safety.

  5. Challenges Of Moving A Bioconjugate Candidate From Clinic To Market

    Drug developers must successfully navigate the path to market, under the growing pressure of regulation and competition, and while carefully managing technical and financial risk.

  6. Environmental Sustainability: Wastewater Incineration Reduction

    Discover an approach to wastewater treatment that reduces the environmental impact of small molecules production and introduces advanced treatment methodologies to avoid wastewater incineration.

  7. From Bench To Batch: Strategies For Scaling HPAPI Production

    Highly potent materials bring additional challenges to manufacturing processes. Examine considerations for optimizing HPAPI production methods to reduce risk and deliver therapies to patients with speed.

  8. New Approaches To Tailored Release Profiles 7/7/2025

    Tailored drug release is evolving from formulation tactic to precision therapy strategy, optimizing timing, site, and rate of delivery for improved patient outcomes.

  9. Nanoscale Technology's Potential: A Fireside Chat With Industry Leaders

    Nanoform CEO Edward Haeggstrom and Shawn Davies, head of drug delivery, biopharmaceuticals development, AstraZeneca, discuss the potential of nanoscale medicines and delivery devices.

  10. Cambrex Scientist Spotlight: Jonas Nilsson 1/29/2025

    Jonas Nilsson, Principal Scientist based in Karlskoga, Sweden, leads a team of synthetic chemists focused on process development and optimization.